P2Y12 inhibitor monotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for P2Y12 inhibitor monotherapy, covering 2024-04-22 to 2024-04-22. Get the full timeline:
Most recent: Clinical Trial Update: P2Y12 Inhibitor Monotherapy Versus Extended DAPT in Patients Treated With Bioresorbable Scaffold [Phase 4]